| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1206.04 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 1923.69 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1617.1 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 1187.53 | 96 |
| GSM780720 | Untreated after 4 days (C2_2) | 1831.74 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 1875.03 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1550.31 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1428.03 | 97 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1153.74 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1554.87 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1297.81 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1175.1 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1450.83 | 97 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1599.87 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1304.99 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1258.46 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1493.76 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1303.02 | 97 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1605.35 | 97 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1358.09 | 97 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1481.65 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1667.72 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1431.98 | 97 |